Evidence map›Paper›PMID 40144968›Full record

ArticleGHM open2024

Analysis of infantile hemangioma without proliferation after birth.

Yusuke Inada, Ami Kawaguchi, Kayo Kunimoto, Tomoyuki Hara, Yutaka Inaba, Yuki Yamamoto, Nobuyuki Kakimoto, Tomohiro Suenaga, Daisuke Tokuhara, Masatoshi Jinnin

Abstract read
In one paragraph

Article in GHM open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yusuke InadaDepartment of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Ami KawaguchiDepartment of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Kayo KunimotoDepartment of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Tomoyuki HaraDepartment of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Yutaka InabaDepartment of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Yuki YamamotoDepartment of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Nobuyuki KakimotoDepartment of Pediatrics, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Tomohiro SuenagaDepartment of Pediatrics, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Daisuke TokuharaDepartment of Pediatrics, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.
Masatoshi JinninDepartment of Dermatology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infantile hemangiomas (IHs) are the most common benign tumors of infancy, occurring in approximately 5-10% of the population. Among what appear to be typical IHs with proliferative and involuting phases, we noticed that there are also IHs that are already present at birth and regress without proliferating. We therefore aimed to determine the frequency and clinical characteristics of this type of IH. A retrospective study was conducted on 176 lesions of 137 Japanese patients with IH. As a result, six lesions (3.4%) in three patients with IH (2.1%) were already present at birth and lacked subsequent proliferation. Analysis of the clinical characteristics of IHs without proliferation revealed that they are significantly less common in the head and neck region, which is the preferred site of the tumor, than typical IHs with proliferation (0%

Indexed as

causepathogenesissubtype

Identifiers

PMID40144968
PMCPMC11933936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.